• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EMD

EMYRIA LIMITED - Corporate Spotlight

8.16% ! 4.5¢
Market Cap $29.34M  !
Healthcare Biotechnology
Add to My Watchlist

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.5¢ 		Change
-0.004(8.16%) 		Mkt cap ! $29.34M
Open High Low Value Volume
4.9¢ 5.0¢ 4.5¢ $114.3K 2.418M

Buyers (Bids)

No. Vol. Price($)
2 245735 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 132390 3
View Market Depth
Last trade - 11.35am 01/08/2025 (20 minute delay) ?
Last
4.6¢ 		  Change
-0.004 ( 5.93 %)
Open High Low Volume
5.0¢ 5.0¢ 4.5¢ 272146
Last updated 11.52am 01/08/2025 ?
EMD (ASX) Chart

Top Stories

Everest Metals dips as company clocks low gold grades at Taipan, WA

Much like results from peer Metal Hawk, which failed to excite on Thursday, Everest Metals Corporation (ASX:EMC) has once again proved that grade is king when it comes to gold @ except the lesson’s in the inverse.Listen to the HotCopper podcast for in-depth discussions and insight...
Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target Executive Director, Ian Goldberg joined The Market Online to discuss their Mumbezhi Project, what could be one of the ASX’s largest copper stories.Join the discussion. See what HotCopper users are saying about Prospect Resources and be part of the conversations that move the marke...
AFT Pharmaceuticals outlines shareholder value focus in 2025 AGM At its annual shareholders meeting in Auckland today, AFT Pharmaceuticals (ASX:AFP) laid out its plans to leverage the company’s R@D pipeline as it hunts out new addressable markets worth as much as US$8 billion.Listen to the HotCopper podcast for in-depth discussions and insights...
Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign Infini Resources’ newly appointed CEO, Rohan Bone joins The Market Online to discuss strategy moving forward. Join the discussion. See what HotCopper users are saying about Infini Resources and be part of the conversations that move the markets.The material provided in this articl...
Crickets as Horizon Oil unveils new project picked up in Thailand Tumbleweeds blew across the boards on Friday as Horizon Oil (ASX:HZN) declared it’s just picked up a fresh new gas project in Thailand.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, an...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.